CompanyGraph
What stands out
- Valued far above the size of its business
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- FinancialsAltman Z-Score 1.84: grey zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Valued far above the size of its business
Financials view
Market Capitalization
5.89BCNY873.02M · vs all stocks (USD)
Revenue (TTM)
330.67MCNY49.04M · vs all stocks (USD)
Profit Margin
-68.18%Beta
0.6210xvs all stocks
52-Week Change
308.85%vs all stocks
Market Capitalization
5.89BCNY873.02M · vs all stocks (USD)
Enterprise Value
7.00BCNY1.04B · vs all stocks (USD)
Price to Sales (TTM)
17.19xPrice to Book (MRQ)
2.77xEnterprise to Revenue
21.16xGross Margin
51.77%Profit Margin
-68.18%Operating Margin
10.60%Return on Assets (TTM)
-0.17%Return on Equity (TTM)
-8.43%Revenue (TTM)
330.67MCNY49.04M · vs all stocks (USD)
Revenue per Share (TTM)
0.4450CNYUpdated Aug 18, 2026Quarterly Revenue Growth
-14.90%Gross Profit (TTM)
91.03MCNY13.50M · vs all stocks (USD)
EBITDA (TTM)
-9.54MCNY-1.41M · vs all stocks (USD)
Net Income (TTM)
-225.46MCNY-33.44M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-51.51%Operating Cash Flow (TTM)
158.26MCNY23.47M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-22.48MCNY-3.33M · vs all stocks (USD)
Payout Ratio
0.00%Minority Interest (Equity)
481.24MCNYFY2025 · Dec 31, 2025Revenue
341.54MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
240.30MCNYFY2025 · Dec 31, 2025Gross Profit
101.24MCNYFY2025 · Dec 31, 2025Operating Income
-1.53MCNY-227.22K · vs all stocks (USD)
Pre-tax Income
-228.11MCNYFY2025 · Dec 31, 2025Income Tax Expense
-12.11MCNYFY2025 · Dec 31, 2025Net Income
-216.00MCNYFY2025 · Dec 31, 2025EBIT
-141.44MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-56.17MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
19.90MCNYFY2025 · Dec 31, 2025Other Operating Expenses
23.11MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
489.94KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
86.67MCNYFY2025 · Dec 31, 2025Net Income from Continuing Operations
-216.00MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-2.21MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-114.97MCNYFY2025 · Dec 31, 2025Free Cash Flow
-119.41MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
49.97MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-216.00MCNYFY2025 · Dec 31, 2025Other Non-cash Items
99.21MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
16.47MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-14.65MCNYFY2025 · Dec 31, 2025Capital Expenditures
-4.44MCNYFY2025 · Dec 31, 2025Other Investing Activity
-1.00MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-5.44MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
60.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-99.46MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-59.51MCNYFY2025 · Dec 31, 2025Other Financing Charges
-67.01MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-165.98MCNYFY2025 · Dec 31, 2025Shares Outstanding
749.91MSharesUpdated Aug 18, 2026Float Shares
749.91MSharesUpdated Aug 18, 2026% Held by Insiders
37.98%vs all stocks
% Held by Institutions
0.00%vs all stocks
Total Cash (MRQ)
29.01MCNY4.30M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.0390CNYUpdated Aug 18, 2026Total Debt (MRQ)
856.60MCNY127.03M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3375xCurrent Ratio (MRQ)
0.1270xBook Value per Share (MRQ)
2.74CNYUpdated Aug 18, 2026Total Assets
4.48BCNY663.99M · vs all stocks (USD)
Total Current Assets
104.79MCNYFY2025 · Dec 31, 2025Total Liabilities
1.92BCNYFY2025 · Dec 31, 2025Total Non-current Assets
4.37BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.28BCNYFY2025 · Dec 31, 2025Total Current Liabilities
634.17MCNYFY2025 · Dec 31, 2025Cash
49.97MCNYFY2025 · Dec 31, 2025Cash Equivalents
8.16MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
58.13MCNYFY2025 · Dec 31, 2025Accounts Receivable
16.57MCNYFY2025 · Dec 31, 2025Accounts Payable
47.48MCNYFY2025 · Dec 31, 2025Short-term Debt
120.45MCNYFY2025 · Dec 31, 2025Other Current Liabilities
26.11MCNYFY2025 · Dec 31, 2025Long-term Debt
879.53MCNYFY2025 · Dec 31, 2025Common Stock (Book)
749.91MCNYFY2025 · Dec 31, 2025Retained Earnings
538.62MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.56BCNY379.44M · vs all stocks (USD)
52-Week Low
1.81CNYUpdated Aug 18, 202652-Week High
8.27CNYUpdated Aug 18, 202652-Week Change
308.85%vs all stocks
Beta
0.6210xvs all stocks
50-Day MA
6.59CNYUpdated Aug 18, 2026200-Day MA
4.21CNYUpdated Aug 18, 2026Avg 10-Day Volume
39.68MSharesUpdated Aug 18, 2026Avg 30-Day Volume
38.28MSharesUpdated Aug 18, 2026Diluted EPS (TTM)
-0.3000CNYUpdated Aug 18, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Valued far above the size of its businessSignificant
Price-to-Sales: 17.19Revenue Growth YoY: -0.15
High gross margins eroded by operating costsNotable
Gross Margin: 0.52Profit Margin: -0.68
Financial Health
Altman Z-Score 1.84: grey zoneSignificant
Altman Z-Score: 1.84
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Beijing North Star Co., Ltd.
Tier 1ProductionUnit ReplicationRiskRule
K. Wah International Holdings Limited
Tier 1ProductionUnit ReplicationRiskRule
Shenzhen Centralcon Investment Holding Co., Ltd.
Tier 1ProductionUnit ReplicationRiskRule
Shenzhen New Nanshan Holding Co., Ltd.
Tier 1ProductionUnit ReplicationRiskFlow
Suning Universal Co., Ltd.
Tier 1ProductionUnit ReplicationRiskRule
Citycon Oyj
Tier 1ProductionUnit ReplicationRiskFlow
Wing Tai Holdings Ltd.
Tier 1ProductionUnit ReplicationRiskRule
Tian An China Investments Company Limited
Tier 1ProductionUnit ReplicationRiskInterface
Mahindra Lifespace Developers Ltd.
Tier 1ProductionUnit ReplicationRiskRule
Lushang Freda Pharmaceutical Co. Ltd.
Tier 1ProductionUnit ReplicationRuleRisk